Prenetics Global Limited Q1 FY2026 Earnings Call

· Earnings call transcript and AI-powered summary

Prenetics Q1 2026 Earnings Summary

Company Context and Transformation

  • Prenetics has shifted from a diagnostics/genome testing business (public in 2022) to a consumer health company anchored by IM8, a premium supplement brand with recurring subscription revenue, global distribution to 43 countries, and focus on unit economics.
  • Over the past 9 months, divested ACT Genomics, Europa, and Insighta to redeploy capital into IM8 growth.
  • IM8 launched 17 months ago with zero revenue; now shipping ~150,000 servings daily and tracking toward ~$186M annualized recurring revenue based on May monthly revenue.

Financial Highlights (Q1 2026 vs. Prior Periods)

  • Total revenue: $36 million on a continuing operations basis, up ~333-334% year-over-year from $8.3 million in Q1 2025.
  • IM8 revenue: $33.8 million, nearly 6x year-over-year and up 23% sequentially from Q4 2025.
  • Gross profit: $23.3 million, up 315% year-over-year.
  • Consolidated gross margin: 64.8%; IM8 gross margin expanded to 64.3%, up ~400 basis points sequentially from Q4 2025 (and from 59.6% a year ago), driven by manufacturing efficiencies, supplier negotiations, favorable mix toward subscriptions, packaging optimization, and fulfillment improvements.

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Greetings, and welcome to the Prenetics first quarter 2026 earnings conference call. As a reminder, this call is being recorded. Your hosts today are Danny Yeung, Chief Executive Officer and Co-founder, and Brian Rosen, CFO of IM8, and Stephen Lo, Chief Financial Officer. Mr. Yeung and Mr. Lo will present results of operations for the first quarter ending March 31st, 2026, and provide a corporate update. A press release detailing these results was re-released today and is available on the investor relations section of our company's website, www.prenetics.com. Before we begin the formal presentation, I'd like to remind everyone that statements made on this call and webcast may include predictions, estimates, and other information that might be considered forward-looking. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially and are not a guarantee of future performance. You're cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we're not obligating ourselves to revise or publicly release the results of any revision of these forward-looking statements in light of new information or future events.

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional